CD8A and deltaretrovirus infections: In the context of HTLV infection, the PVL is also correlated with the level of circulating antibodies [14,15] and the specific CD8+ lymphocyte response contributes to the control of the PVL and is associated with a lower risk of clinical disease progression [16].